(Q59314008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Predicting beta-interferon failure in relapsing-remitting multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

29 December 2019

main subject

multiple sclerosis

0 references

0 references

author

Cathal Walsh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michael Hutchinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

O'Rourke K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Antonelli G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

29 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

336-342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Defining interferon beta response status in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Clinical characteristics of responders to interferon therapy for relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Effect of relapses on development of residual deficit in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506071309

21 January 2018

Identifiers

DOI

10.1177/1352458506071309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439902%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference